Evaluation of antimicrobial activity of β-lactam antibodies by Etest against clinical isolates

Japanese Journal of Chemotherapy

Volumn 50, Issue 5, 2002, Pages 259-265

  Ishii, Yoshikazu ^a   Ma, Ling ^a   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

lactams; Cefeptime; Drug resistance; Etest; Susceptibility

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOPERAZONE; CEFPIROME; CEFTAZIDIME; IMIPENEM; OXACILLIN; PIPERACILLIN; SULBACTAM;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CITROBACTER; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG SCREENING; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; PROTEUS; PSEUDOMONAS AERUGINOSA; SERRATIA; STAPHYLOCOCCUS AUREUS;

EID: 0036304158     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. A standard numbering scheme for the class A β-lactamases
2. A functional classification scheme for β-lactamases and its correlation with molecular structure
3. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
4. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli
5. Chromosomal cephalosporinases responsible for multiple resistance to newer β-lactam antibiotics
6. Protein D 2 porin of the Pseudomonas aeruginosa outer membrane bears the protease activity
7. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa
8. Extended spectrum β-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family
9. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan
10. Sequence and comparative analysis of three Enterobacter cloacae ampC β-lactamase genes and their products
11. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins
12. Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidine and cefotaxime
13. Characterization of OXA-25, OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii
14. IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998
15. Biochemical characterization of chromosomal cephalosporinases from isolates belonging to the Acinetobacter baumannii complex
16. Clinical importance of extended-spectrum β-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains